180 related articles for article (PubMed ID: 9558399)
1. A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia.
Legras S; Günthert U; Stauder R; Curt F; Oliferenko S; Kluin-Nelemans HC; Marie JP; Proctor S; Jasmin C; Smadja-Joffe F
Blood; 1998 May; 91(9):3401-13. PubMed ID: 9558399
[TBL] [Abstract][Full Text] [Related]
2. Different CD44 splicing patterns define prognostic subgroups in multiple myeloma.
Stauder R; Van Driel M; Schwärzler C; Thaler J; Lokhorst HM; Kreuser ED; Bloem AC; Günthert U; Eisterer W
Blood; 1996 Oct; 88(8):3101-8. PubMed ID: 8874209
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells.
Bendall LJ; Bradstock KF; Gottlieb DJ
Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548
[TBL] [Abstract][Full Text] [Related]
4. Expression and modulation of CD44 variant isoforms in humans.
Mackay CR; Terpe HJ; Stauder R; Marston WL; Stark H; Günthert U
J Cell Biol; 1994 Jan; 124(1-2):71-82. PubMed ID: 7507492
[TBL] [Abstract][Full Text] [Related]
5. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
[TBL] [Abstract][Full Text] [Related]
6. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.
Stauder R; Eisterer W; Thaler J; Günthert U
Blood; 1995 May; 85(10):2885-99. PubMed ID: 7537983
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.
Terpe HJ; Störkel S; Zimmer U; Anquez V; Fischer C; Pantel K; Günthert U
Am J Pathol; 1996 Feb; 148(2):453-63. PubMed ID: 8579108
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic characterization of alternatively spliced CD44 transcripts in human stomach carcinoma.
Kim YS; Chi SG; Kim YW; Park YK; Yoon C
J Korean Med Sci; 1997 Dec; 12(6):505-13. PubMed ID: 9443088
[TBL] [Abstract][Full Text] [Related]
9. Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia.
Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K
Hematol Oncol; 1998 Dec; 16(4):131-41. PubMed ID: 10414233
[TBL] [Abstract][Full Text] [Related]
10. CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues.
Terpe HJ; Stark H; Prehm P; Günthert U
Histochemistry; 1994 Feb; 101(2):79-89. PubMed ID: 7520892
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumor progression.
Khaldoyanidi S; Achtnich M; Hehlmann R; Zöller M
Leuk Res; 1996 Oct; 20(10):839-51. PubMed ID: 8960109
[TBL] [Abstract][Full Text] [Related]
12. The role of alternative splicing of the adhesion molecule, CD44, in lymphoid malignancy.
Irving JA; Cain G; Howard M; Angus B; Taylor PR; Cattan AR
J Clin Pathol; 1998 Oct; 51(10):776-80. PubMed ID: 10023342
[TBL] [Abstract][Full Text] [Related]
13. Are CD44 variant isoforms involved in human tumour progression?
Günthert U; Stauder R; Mayer B; Terpe HJ; Finke L; Friedrichs K
Cancer Surv; 1995; 24():19-42. PubMed ID: 7553660
[TBL] [Abstract][Full Text] [Related]
14. Differential expressions of CD44 variants in tumors affecting the central nervous system.
Resnick DK; Resnick NM; Welch WC; Cooper DL
Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
[TBL] [Abstract][Full Text] [Related]
15. CD44 splice variant expression in clear cell carcinoma of the ovary.
Rodríguez-Rodríguez L; Sancho-Torres I; Leakey P; Gibbon DG; Comerci JT; Ludlow JW; Mesonero C
Gynecol Oncol; 1998 Nov; 71(2):223-9. PubMed ID: 9826464
[TBL] [Abstract][Full Text] [Related]
16. Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia.
Ghaffari S; Dougherty GJ; Lansdorp PM; Eaves AC; Eaves CJ
Blood; 1995 Oct; 86(8):2976-85. PubMed ID: 7579390
[TBL] [Abstract][Full Text] [Related]
17. Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas.
Terpe HJ; Koopmann R; Imhof BA; Günthert U
J Pathol; 1994 Oct; 174(2):89-100. PubMed ID: 7525912
[TBL] [Abstract][Full Text] [Related]
18. No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer.
Givehchian M; Wörner S; Sträter J; Zöller M; Heuschen U; Heuschen G; Lehnert T; Herfarth C; von Knebel Doeberitz M
Eur J Cancer; 1998 Jun; 34(7):1099-1104. PubMed ID: 9849461
[TBL] [Abstract][Full Text] [Related]
19. CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease.
van Driel M; Günthert U; Stauder R; Joling P; Lokhorst HM; Bloem AC
Leukemia; 1998 Nov; 12(11):1821-8. PubMed ID: 9823960
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of CD44 variant exon expression in endometrial carcinomas: analysis of mRNA and protein isoforms, and relation to clinicopathological factors.
Saegusa M; Okayasu I
Jpn J Cancer Res; 1998 Mar; 89(3):291-8. PubMed ID: 9600123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
